DIABLO
Basic information
Region (hg38): 12:122207668-122226062
Links
Phenotypes
GenCC
Source:
- autosomal dominant nonsyndromic hearing loss 64 (Moderate), mode of inheritance: AD
- autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
- autosomal dominant nonsyndromic hearing loss 64 (Limited), mode of inheritance: AD
- nonsyndromic genetic hearing loss (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal dominant 64 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic | 21722859 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DIABLO gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 12 | ||||
missense | 33 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 24 | 19 | 45 | |||
Total | 0 | 0 | 40 | 41 | 21 |
Variants in DIABLO
This is a list of pathogenic ClinVar variants found in the DIABLO region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-122208118-T-TA | Benign (Dec 10, 2018) | |||
12-122208273-T-C | Benign (Jun 22, 2018) | |||
12-122208303-C-T | Likely benign (Jun 13, 2021) | |||
12-122208327-A-G | Benign (Jun 16, 2018) | |||
12-122208383-A-G | Autosomal dominant nonsyndromic hearing loss 64 | Likely pathogenic (May 06, 2024) | ||
12-122208388-TCACGCAGGTAG-T | Hearing impairment | Uncertain significance (Feb 04, 2022) | ||
12-122208391-C-G | not specified | Uncertain significance (Jan 30, 2024) | ||
12-122208391-C-T | Uncertain significance (Nov 21, 2022) | |||
12-122208392-G-A | Uncertain significance (Mar 01, 2023) | |||
12-122208400-GCCTCCTGCTCCGACTCAGCCCGCT-G | DIABLO-related disorder | Likely benign (Dec 17, 2020) | ||
12-122208401-CC-AG | Uncertain significance (Feb 04, 2022) | |||
12-122208411-C-T | not specified | Benign (Jan 29, 2024) | ||
12-122208412-G-A | Uncertain significance (Jan 11, 2024) | |||
12-122208426-C-T | Likely benign (Jul 11, 2022) | |||
12-122208431-C-T | not specified • DIABLO-related disorder | Benign/Likely benign (Jan 07, 2024) | ||
12-122208441-T-C | not specified | Likely benign (Jan 16, 2018) | ||
12-122208465-CTG-C | not specified | Uncertain significance (May 21, 2019) | ||
12-122208474-T-C | Likely benign (Oct 22, 2022) | |||
12-122208487-T-G | Uncertain significance (Jul 17, 2022) | |||
12-122208490-G-A | Uncertain significance (Dec 25, 2023) | |||
12-122208496-C-T | Autosomal dominant nonsyndromic hearing loss 64 | Conflicting classifications of pathogenicity (Apr 11, 2023) | ||
12-122208497-G-A | DIABLO-related disorder | Uncertain significance (May 03, 2023) | ||
12-122208508-T-C | Uncertain significance (Dec 06, 2022) | |||
12-122208534-C-T | Likely benign (Nov 14, 2022) | |||
12-122208555-G-A | not specified | Benign/Likely benign (Nov 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DIABLO | protein_coding | protein_coding | ENST00000443649 | 6 | 19872 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000257 | 0.522 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.12 | 161 | 126 | 1.28 | 0.00000711 | 1529 |
Missense in Polyphen | 57 | 48.708 | 1.1702 | 614 | ||
Synonymous | -2.22 | 65 | 45.9 | 1.42 | 0.00000239 | 467 |
Loss of Function | 0.764 | 10 | 13.0 | 0.771 | 6.46e-7 | 158 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000239 | 0.000239 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000192 | 0.000185 |
European (Non-Finnish) | 0.000172 | 0.000167 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000181 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes apoptosis by activating caspases in the cytochrome c/Apaf-1/caspase-9 pathway. Acts by opposing the inhibitory activity of inhibitor of apoptosis proteins (IAP). Inhibits the activity of BIRC6/bruce by inhibiting its binding to caspases. Isoform 3 attenuates the stability and apoptosis- inhibiting activity of XIAP/BIRC4 by promoting XIAP/BIRC4 ubiquitination and degradation through the ubiquitin-proteasome pathway. Isoform 3 also disrupts XIAP/BIRC4 interacting with processed caspase-9 and promotes caspase-3 activation. Isoform 1 is defective in the capacity to down-regulate the XIAP/BIRC4 abundance. {ECO:0000269|PubMed:10929711, ECO:0000269|PubMed:14523016, ECO:0000269|PubMed:15200957}.;
- Disease
- DISEASE: Deafness, autosomal dominant, 64 (DFNA64) [MIM:614152]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:21722859}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Apoptosis - multiple species - Homo sapiens (human);Apoptosis - Homo sapiens (human);Apoptosis Modulation and Signaling;TNF alpha Signaling Pathway;Nanomaterial induced apoptosis;Apoptosis;Apoptotic Signaling Pathway;role of mitochondria in apoptotic signaling;Release of apoptotic factors from the mitochondria;SMAC-mediated dissociation of IAP:caspase complexes ;SMAC-mediated apoptotic response;Apoptotic factor-mediated response;Intrinsic Pathway for Apoptosis;Apoptosis;Programmed Cell Death;SMAC binds to IAPs ;TNFalpha;Caspase Cascade in Apoptosis;p75(NTR)-mediated signaling
(Consensus)
Intolerance Scores
- loftool
- 0.603
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 38.58
Haploinsufficiency Scores
- pHI
- 0.0999
- hipred
- Y
- hipred_score
- 0.562
- ghis
- 0.583
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.928
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Diablo
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; cellular phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;extrinsic apoptotic signaling pathway via death domain receptors;intrinsic apoptotic signaling pathway in response to oxidative stress;activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c;positive regulation of apoptotic process;neuron apoptotic process;intrinsic apoptotic signaling pathway
- Cellular component
- mitochondrion;mitochondrial intermembrane space;cytosol;cytoplasmic side of plasma membrane;CD40 receptor complex
- Molecular function
- protein binding